-
Je něco špatně v tomto záznamu ?
Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression
J. Sirc, Z. Hampejsova, J. Trnovska, P. Kozlik, J. Hrib, R. Hobzova, A. Zajicova, V. Holan, Z. Bosakova,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
NLK
ProQuest Central
od 1997-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2010-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1997-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 1997-01-01 do Před 1 rokem
- MeSH
- buněčné linie MeSH
- cyklosporin aplikace a dávkování chemie MeSH
- hydrofobní a hydrofilní interakce MeSH
- imunosupresiva aplikace a dávkování chemie MeSH
- kinetika MeSH
- kultivační média MeSH
- lidé MeSH
- nanovlákna chemie MeSH
- nosiče léků MeSH
- polyestery chemie MeSH
- polyethylenglykoly chemie MeSH
- povrchové vlastnosti MeSH
- slezina cytologie MeSH
- techniky tkáňových kultur MeSH
- uvolňování léčiv MeSH
- velikost částic MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: The present study aims to prepare poly(D,L-lactic acid) (PLA) nanofibers loaded by the immunosuppressant cyclosporine A (CsA, 10 wt%). Amphiphilic poly(ethylene glycol)s (PEG) additives were used to modify the hydrophobic drug release kinetics. METHODS: Four types of CsA-loaded PLA nanofibrous carriers varying in the presence and molecular weight (MW) of PEG (6, 20 and 35 kDa) were prepared by needleless electrospinning. The samples were extracted for 144 h in phosphate buffer saline or tissue culture medium. A newly developed and validated LC-MS/MS method was utilized to quantify the amount of released CsA from the carriers. In vitro cell experiments were used to evaluate biological activity. RESULTS: Nanofibers containing 15 wt% of PEG showed improved drug release characteristics; significantly higher release rates were achieved in initial part of experiment (24 h). The highest released doses of CsA were obtained from the nanofibers with PEG of the lowest MW (6 kDa). In vitro experiments on ConA-stimulated spleen cells revealed the biological activity of the released CsA for the whole study period of 144 h and nanofibers containing PEG with the lowest MW exhibited the highest impact (inhibition). CONCLUSIONS: The addition of PEG of a particular MW enables to control CsA release from PLA nanofibrous carriers. The biological activity of CsA-loaded PLA nanofibers with PEG persists even after 144 h of previous extraction. Prepared materials are promising for local immunosuppression in various medical applications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025084
- 003
- CZ-PrNML
- 005
- 20180718101911.0
- 007
- ta
- 008
- 180709s2017 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s11095-017-2155-x $2 doi
- 035 __
- $a (PubMed)28405914
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sirc, Jakub $u Department of Polymer Networks and Gels, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
- 245 10
- $a Cyclosporine A Loaded Electrospun Poly(D,L-Lactic Acid)/Poly(Ethylene Glycol) Nanofibers: Drug Carriers Utilizable in Local Immunosuppression / $c J. Sirc, Z. Hampejsova, J. Trnovska, P. Kozlik, J. Hrib, R. Hobzova, A. Zajicova, V. Holan, Z. Bosakova,
- 520 9_
- $a PURPOSE: The present study aims to prepare poly(D,L-lactic acid) (PLA) nanofibers loaded by the immunosuppressant cyclosporine A (CsA, 10 wt%). Amphiphilic poly(ethylene glycol)s (PEG) additives were used to modify the hydrophobic drug release kinetics. METHODS: Four types of CsA-loaded PLA nanofibrous carriers varying in the presence and molecular weight (MW) of PEG (6, 20 and 35 kDa) were prepared by needleless electrospinning. The samples were extracted for 144 h in phosphate buffer saline or tissue culture medium. A newly developed and validated LC-MS/MS method was utilized to quantify the amount of released CsA from the carriers. In vitro cell experiments were used to evaluate biological activity. RESULTS: Nanofibers containing 15 wt% of PEG showed improved drug release characteristics; significantly higher release rates were achieved in initial part of experiment (24 h). The highest released doses of CsA were obtained from the nanofibers with PEG of the lowest MW (6 kDa). In vitro experiments on ConA-stimulated spleen cells revealed the biological activity of the released CsA for the whole study period of 144 h and nanofibers containing PEG with the lowest MW exhibited the highest impact (inhibition). CONCLUSIONS: The addition of PEG of a particular MW enables to control CsA release from PLA nanofibrous carriers. The biological activity of CsA-loaded PLA nanofibers with PEG persists even after 144 h of previous extraction. Prepared materials are promising for local immunosuppression in various medical applications.
- 650 _2
- $a buněčné linie $7 D002460
- 650 _2
- $a kultivační média $7 D003470
- 650 _2
- $a cyklosporin $x aplikace a dávkování $x chemie $7 D016572
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a uvolňování léčiv $7 D065546
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrofobní a hydrofilní interakce $7 D057927
- 650 _2
- $a imunosupresiva $x aplikace a dávkování $x chemie $7 D007166
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a nanovlákna $x chemie $7 D057139
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a polyestery $x chemie $7 D011091
- 650 _2
- $a polyethylenglykoly $x chemie $7 D011092
- 650 _2
- $a slezina $x cytologie $7 D013154
- 650 _2
- $a povrchové vlastnosti $7 D013499
- 650 _2
- $a techniky tkáňových kultur $7 D046509
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hampejsova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Trnovska, Jana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Kozlik, Petr $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic.
- 700 1_
- $a Hrib, Jakub $u Department of Polymer Networks and Gels, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
- 700 1_
- $a Hobzova, Radka $u Department of Polymer Networks and Gels, Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovsky Sq. 2, 162 06, Prague 6, Czech Republic.
- 700 1_
- $a Zajicova, Alena $u Department of Transplantation Immunology, Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
- 700 1_
- $a Holan, Vladimir $u Department of Transplantation Immunology, Institute of Experimental Medicine, Czech Academy of Sciences, Videnska 1083, 142 20, Prague 4, Czech Republic.
- 700 1_
- $a Bosakova, Zuzana $u Department of Analytical Chemistry, Faculty of Science, Charles University, Hlavova 8, 128 43, Prague 2, Czech Republic. bosakova@natur.cuni.cz.
- 773 0_
- $w MED00003779 $t Pharmaceutical research $x 1573-904X $g Roč. 34, č. 7 (2017), s. 1391-1401
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28405914 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180709 $b ABA008
- 991 __
- $a 20180718102212 $b ABA008
- 999 __
- $a ok $b bmc $g 1317215 $s 1022005
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 34 $c 7 $d 1391-1401 $e 20170412 $i 1573-904X $m Pharmaceutical research $n Pharm Res $x MED00003779
- LZP __
- $a Pubmed-20180709